Teradata Shorts Sit Heavy Before Monday's Print

Teradata Corporation reports third-quarter results on Monday, November 2, carrying a short position that accounts for nearly 16% of its free float and an activist on its register who has been quietly reducing a stake built just over a year ago.

Short interest at 15.9% of free float is material, and it has edged higher over the past week, adding roughly 4.2% in shares shorted. That is against a backdrop where the stock has rallied 19% over the past month to $34.25, meaning a meaningful portion of the short book is now sitting underwater. Days to cover, at around eight, reinforces just how concentrated that position is relative to normal trading volumes. Despite the elevated short interest, borrow conditions offer little signal of a pending squeeze: availability runs at 386%, meaning roughly three and a half shares remain available to lend for every one currently borrowed, and the cost to borrow is an unremarkable 0.43%. Short sellers are not paying up to maintain their positions, and supply in the lending pool is ample.

Options positioning has shifted more defensive in recent sessions. The put/call ratio moved to 0.55, against a 20-day average closer to 0.42, placing it about one standard deviation above recent norms. That is notable but not extreme, given the 52-week range runs from 0.05 to 1.13. What makes it more interesting is the timing: the PCR sat near its lowest readings of the year through much of October before reversing sharply higher in the latter half of the month, coinciding with the stock's approach toward the print.

The analyst debate around Teradata reflects a company that the Street has struggled to price consistently. Citigroup raised its target to $40 from $36 on Friday, maintaining a Buy rating, and its target now sits comfortably above the current price. That stands against a less constructive picture from other corners: Morgan Stanley downgraded to Equal-Weight in August and cut its target to $29, while Barclays has maintained an Underweight rating with a $27 target throughout the year. The mean price target across the consensus is $33.50, which at the current price of $34.25 implies the stock has already run through where most analysts thought fair value lay. The bull case rests on Teradata's positioning in enterprise AI and data management, where its existing customer relationships provide switching-cost protection. The bear case focuses on competitive pressure from larger cloud vendors and questions about whether the company's multi-cloud platform can grow revenue in an environment where AI workloads are increasingly processed closer to the source.

Lynrock Lake, an activist holder that first filed a Schedule 13D in March 2025, appears on the register with a 6.6% stake, trimmed from 7.6% as of its July 2026 amendment. Activist filings are event-driven disclosures around the 5% threshold, and positions can fall below that level without a subsequent filing, so the current stake should be read as last-disclosed rather than confirmed. BlackRock added significantly during the most recent period to reach 17.6% of shares, making it the dominant institutional voice. The August print was a painful one: shares fell more than 18% after those results, with the losses extending further over the following week. That reaction still looms over the setup.

The November 2 report is therefore a direct test of whether the October rally has correctly priced an improvement in the company's trajectory, or whether it has simply recovered ground ahead of a print that risks repeating the August experience.